Impact of coronary artery bypass grafting surgery on the chorioretinal biomicroscopic characteristics.
Coronary artery bypass grafting
Diabetic retinopathy
Hypertensive retinopathy
Nerve fiber layer
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
06 Oct 2023
06 Oct 2023
Historique:
received:
22
05
2023
revised:
21
08
2023
accepted:
25
08
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
ppublish
Résumé
Most patients with cardiovascular disorders suffer from coronary artery diseases, which can be treated successfully using coronary artery bypass grafting (CABG). One of the unpleasant events following CABG is postoperative vision loss (POVL). Vulnerability of retinal vessels to hemodynamic changes, an expectable event following CABG, may contribute to the development of POVL, which might be associated with the changes in the choroidal and retinal structures. To investigate postoperative changes in chorioretinal and peripapillary nerve fiber layer (NFL) thickness, and progression of diabetic and hypertensive retinopathy after CABG. In this prospective, cross-sectional study, 49 eyes in 25 candidates for CABG underwent both ophthalmic and cardiovascular examinations within 6 mo prior to and 9 mo after surgery. Among the study participants, 56% were male with a mean age of 62.84 years ± 10.49 years (range 33-80 years). Diabetes mellitus was observed in eight participants (32%). None of the patients suffered from postoperative anterior or posterior ischemic optic neuropathy, central retinal artery occlusion, and cortical blindness. The mean value of the preoperative best corrected visual acuity was 0.11 ± 0.10 logMAR (range, 0-0.4), which worsened to 0.15 ± 0.08 logMAR (range, 0-0.4) after CABG ( CABG may reduce visual acuity without affecting ocular structures. Postoperative vision reduction might be attributable to molecular or cellular variations, changes in visual pathway function, or central nervous system.
Sections du résumé
BACKGROUND
BACKGROUND
Most patients with cardiovascular disorders suffer from coronary artery diseases, which can be treated successfully using coronary artery bypass grafting (CABG). One of the unpleasant events following CABG is postoperative vision loss (POVL). Vulnerability of retinal vessels to hemodynamic changes, an expectable event following CABG, may contribute to the development of POVL, which might be associated with the changes in the choroidal and retinal structures.
AIM
OBJECTIVE
To investigate postoperative changes in chorioretinal and peripapillary nerve fiber layer (NFL) thickness, and progression of diabetic and hypertensive retinopathy after CABG.
METHODS
METHODS
In this prospective, cross-sectional study, 49 eyes in 25 candidates for CABG underwent both ophthalmic and cardiovascular examinations within 6 mo prior to and 9 mo after surgery.
RESULTS
RESULTS
Among the study participants, 56% were male with a mean age of 62.84 years ± 10.49 years (range 33-80 years). Diabetes mellitus was observed in eight participants (32%). None of the patients suffered from postoperative anterior or posterior ischemic optic neuropathy, central retinal artery occlusion, and cortical blindness. The mean value of the preoperative best corrected visual acuity was 0.11 ± 0.10 logMAR (range, 0-0.4), which worsened to 0.15 ± 0.08 logMAR (range, 0-0.4) after CABG (
CONCLUSION
CONCLUSIONS
CABG may reduce visual acuity without affecting ocular structures. Postoperative vision reduction might be attributable to molecular or cellular variations, changes in visual pathway function, or central nervous system.
Identifiants
pubmed: 37901009
doi: 10.12998/wjcc.v11.i28.6754
pmc: PMC10600861
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6754-6762Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Références
Perfusion. 2015 May;30(4):312-7
pubmed: 25114018
Eye (Lond). 2020 Nov;34(11):2068-2075
pubmed: 31992862
Insight. 2005 Jan-Mar;30(1):10-7
pubmed: 15945413
Scand Cardiovasc J. 2008 Oct;42(5):337-44
pubmed: 18609064
Acta Ophthalmol. 2021 Aug;99(5):545-552
pubmed: 33354923
Circulation. 2005 Dec 20;112(25):3833-8
pubmed: 16365207
Anesthesiol Clin North Am. 2002 Sep;20(3):605-622, viii
pubmed: 12298309
J Cardiothorac Vasc Anesth. 2019 May;33(5):1420-1429
pubmed: 30616896
Int Ophthalmol. 2021 Jun;41(6):2117-2124
pubmed: 33728490
PLoS One. 2017 Jun 20;12(6):e0175691
pubmed: 28632734
J Cardiothorac Surg. 2011 Nov 21;6:154
pubmed: 22104114
Photodiagnosis Photodyn Ther. 2021 Mar;33:102189
pubmed: 33497818
Glob J Health Sci. 2014 Mar 24;6(3):186-93
pubmed: 24762361
J Perianesth Nurs. 2010 Feb;25(1):29-35
pubmed: 20159532
Am J Ophthalmol. 2004 May;137(5):938-40
pubmed: 15126164
N Engl J Med. 2001 Apr 12;344(15):1117-24
pubmed: 11297702
Circulation. 1999 Sep 28;100(13):1464-80
pubmed: 10500052
Diagnostics (Basel). 2022 Aug 20;12(8):
pubmed: 36010366
Curr Pharm Des. 2019;25(38):4063-4084
pubmed: 31553287
J Cardiothorac Surg. 2013 Apr 02;8:59
pubmed: 23547910
Curr Cardiol Rep. 2019 Apr 22;21(6):45
pubmed: 31011838
Control Clin Trials. 2000 Dec;21(6):595-609
pubmed: 11146152
N Engl J Med. 2009 Mar 5;360(10):961-72
pubmed: 19228612
Perfusion. 2007 Nov;22(6):401-6
pubmed: 18666743
Anesthesiology. 2019 Jan;130(1):12-30
pubmed: 30531555
Curr Opin Anaesthesiol. 2010 Oct;23(5):582-7
pubmed: 20802327